Private company
L5 Capital Inc.
Last updated Oct 21, 2026.
Overview
Corporate structure
L5 Capital Inc. sits at the top of its group. 3 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- L5 Capital Inc.
- BriaCell Therapeutics Corp. Stake · West Vancouver, British Columbia, Canada
- HTG MOLECULAR DIAGNOSTICS, INC Stake · Tucson, Arizona, United States
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.
Stakes it holds
L5 Capital Inc. has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).
- BriaCell Therapeutics Corp.SC 13D/A May 24, 2024 to Dec 12, 20242
- HTG MOLECULAR DIAGNOSTICS, INCSC 13G/A Jun 29, 2022 to Jul 18, 20223
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARL5 Capital Inc. filings on SEC EDGAR
- 2
- 3